We are live on
!
Find out more
HRCM
Hood River Capital Management Portfolio holdings
AUM
$9.98B
1-Year Est. Return
145.42%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+145.42%
3 Year Est. Return
+584.57%
5 Year Est. Return
+927.1%
10 Year Est. Return
+12,185.37%
AUM
$3.34B
AUM Growth
+$103M
(+3.2%)
Cap. Flow
-$73.7M
Cap. Flow
% of AUM
-2.21%
Top 10 Holdings %
Top 10 Hldgs %
31.01%
Holding
181
New
34
Increased
58
Reduced
45
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$37.8M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$27.3M |
| 3 |
LPRO
Open Lending Corp
LPRO
|
+$22.9M |
| 4 |
Lantheus
LNTH
|
+$22.1M |
| 5 |
BASE
Couchbase
BASE
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Upbound Group
UPBD
|
+$71.8M |
| 2 |
Kulicke & Soffa
KLIC
|
+$62.1M |
| 3 |
SEM
Select Medical
SEM
|
+$47.2M |
| 4 |
AZUL
Azul
AZUL
|
+$29.8M |
| 5 |
Magnite
MGNI
|
+$22.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.11% |
| 2 | Industrials | 22.66% |
| 3 | Healthcare | 18.78% |
| 4 | Consumer Discretionary | 16.72% |
| 5 | Financials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Upbound Group
UPBD
$1.12B
| – | – |
-1,276,821
| Closed | -$71.8M |
|
|
WKME
127
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| – | – |
-368,563
| Closed | -$11M |
|
|
DCPH
128
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-216,557
| Closed | -$7.36M |
|
|
OTMO
129
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
| – | – |
-30,000
| Closed | -$2.15M |
|
|
VVNT
130
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| – | – |
-54,582
| Closed | -$516K |
|
|
LHCG
131
DELISTED
LHC Group LLC
LHCG
| – | – |
-67,726
| Closed | -$10.6M |
|
|
TSC
132
DELISTED
TriState Capital Holdings, Inc.
TSC
| – | – |
-960,599
| Closed | -$20.3M |
|
Similar funds
RI
HI
MF
RA
GI
ACA
MPI
URS
Hood River Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Hood River Capital Management held 181 positions worth $3.34B, up 3.2% from $3.24B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Hood River Capital Management's Q4 2021 filing shows 34 new, 58 increased, 45 reduced and 34 closed positions. Its largest new stake was Tandem Diabetes Care: 279,895 shares worth $42.1M. The largest sale was Upbound Group, an estimated $71.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Healthcare.
- Hood River Capital Management's largest Q4 2021 buy was Tandem Diabetes Care: 279,895 shares worth $42.1M.
- Hood River Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q4 2021, an estimated $27.3M increase.
- Hood River Capital Management's biggest Q4 2021 reduction was Select Medical, cutting an estimated $47.2M.
- Hood River Capital Management fully exited Upbound Group in Q4 2021, selling an estimated $71.8M.
- Hood River Capital Management's ten largest holdings make up 31% of its $3.34B portfolio in Q4 2021.
- Hood River Capital Management opened 34 new positions and closed 34 in Q4 2021.
- Hood River Capital Management's portfolio value rose 3.2% quarter-over-quarter to $3.34B.
Based on Hood River Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.